Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre C Kalil

Showing results (101-110 of 277) with videos related to

Pageof 28
Sort By:
Critical Care Medicine|April 16, 2019
Saved From Sepsis: Can Immunotherapy Improve Acute and Postacute Outcomes?Kelly A Cawcutt, Andre C Kalil
Lancet (London, England)|January 7, 2014
Probiotics and antibiotic-associated diarrhoeaAndre C Kalil, Trevor C Schooneveld
The Lancet. Infectious Diseases|July 20, 2012
Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregressionAndre C Kalil, Steven P LaRosa
Critical Care Medicine|February 22, 2023
Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19Kelly A Cawcutt, Andre C Kalil
Critical Care Medicine|November 17, 2022
Immunomodulators in Mechanically Ventilated Patients With COVID-19: Lessons Learned From Underpowered TrialsCarlos A Gomez, Andre C Kalil
Infectious Disease Clinics of North America|January 27, 2024
Management of Ventilator-Associated Pneumonia: GuidelinesMark L Metersky, Andre C Kalil
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2026
Can Influenza virus cause bacteremia, sepsis, and septic shock?Andre C Kalil, Kelly A Cawcutt
NEJM Evidence|February 6, 2024
Molnupiravir: Is It Time to Move In or Move Out?Natalia E Castillo Almeida, Andre C Kalil
Critical Care Medicine|December 20, 2011
Is the evidence for benefits from ventilator-associated pneumonia bundles reliable enough for implementation in a general hospital?Andre C Kalil, Jeanine P Wiener-Kronish
Intensive Care Medicine|July 19, 2019
Changes in lung microbiome do not explain the development of ventilator-associated pneumoniaLieuwe D J Bos, Andre C Kalil
Pageof 28

Showing results (101-110 of 277) with videos related to

Sort By:
Pageof 28
Critical Care Medicine|April 16, 2019
Saved From Sepsis: Can Immunotherapy Improve Acute and Postacute Outcomes?Kelly A Cawcutt, Andre C Kalil
Lancet (London, England)|January 7, 2014
Probiotics and antibiotic-associated diarrhoeaAndre C Kalil, Trevor C Schooneveld
The Lancet. Infectious Diseases|July 20, 2012
Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregressionAndre C Kalil, Steven P LaRosa
Critical Care Medicine|February 22, 2023
Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19Kelly A Cawcutt, Andre C Kalil
Critical Care Medicine|November 17, 2022
Immunomodulators in Mechanically Ventilated Patients With COVID-19: Lessons Learned From Underpowered TrialsCarlos A Gomez, Andre C Kalil
Infectious Disease Clinics of North America|January 27, 2024
Management of Ventilator-Associated Pneumonia: GuidelinesMark L Metersky, Andre C Kalil
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2026
Can Influenza virus cause bacteremia, sepsis, and septic shock?Andre C Kalil, Kelly A Cawcutt
NEJM Evidence|February 6, 2024
Molnupiravir: Is It Time to Move In or Move Out?Natalia E Castillo Almeida, Andre C Kalil
Critical Care Medicine|December 20, 2011
Is the evidence for benefits from ventilator-associated pneumonia bundles reliable enough for implementation in a general hospital?Andre C Kalil, Jeanine P Wiener-Kronish
Intensive Care Medicine|July 19, 2019
Changes in lung microbiome do not explain the development of ventilator-associated pneumoniaLieuwe D J Bos, Andre C Kalil
Pageof 28